v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 71,337 $ 105,369
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 25,271 11,611
Distributions from unconsolidated investment 0 7,840
Equity in (earnings) loss from unconsolidated investment 16,859 (4,746)
Gain on asset sales and disposals (49) (1,882)
Asset impairments 0 20
Bad debt expense (690) 862
Unit-based compensation expense 5,408 8,103
Amortization of debt issuance costs and other 1,207 (81)
Change in operating assets and liabilities:    
Accounts receivable 1,958 346
Accounts payable (208) (23)
Accrued liabilities (3,868) (5,336)
Accrued interest 173 190
Deferred revenue (1,134) (2,636)
Other items, net 1,692 1,461
Net cash provided by operating activities 117,956 121,098
Cash flows from investing activities    
Proceeds from asset sales and disposals 51 1,883
Capital to unconsolidated investment (39,200) 0
Return of long-term contract receivable 2,318 2,142
Net cash provided by (used in) investing activities (36,831) 4,025
Cash flows from financing activities    
Debt borrowings 67,200 33,700
Debt repayments (86,084) (106,500)
Distributions to common unitholders and the general partner (32,044) (46,386)
Other items, net (8,646) (5,362)
Net cash used in financing activities (59,574) (124,548)
Net increase in cash and cash equivalents 21,551 575
Cash and cash equivalents at beginning of period 30,141 30,444
Cash and cash equivalents at end of period 51,692 31,019
Supplemental cash flow information:    
Cash paid for interest $ 2,198 $ 6,509